Viewing Study NCT00004005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-01-24 @ 11:24 PM
Study NCT ID: NCT00004005
Status: COMPLETED
Last Update Posted: 2017-04-26
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
Sponsor: St. Jude Children's Research Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma of Unknown Primary View
None Colorectal Cancer View
None Unspecified Adult Solid Tumor, Protocol Specific View
None Unspecified Childhood Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III colon cancer View
None stage IV colon cancer View
None stage III rectal cancer View
None stage IV rectal cancer View
None unspecified childhood solid tumor, protocol specific View
None unspecified adult solid tumor, protocol specific View
None adenocarcinoma of unknown primary View
None newly diagnosed carcinoma of unknown primary View
None recurrent carcinoma of unknown primary View